Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation

被引:0
|
作者
Mónica Acevedo
Ramón Corbalán
Sandra Braun
Jaime Pereira
Ilse González
Carlos Navarrete
机构
[1] Pontificia Universidad Católica de Chile,Facultad de Medicina, División de Enfermedades Cardiovasculares
[2] Pontificia Universidad Católica de Chile,Facultad de Medicina, Departamento de Hematología
[3] Universidad de la Serena,Departamento de Matemáticas
来源
Journal of Thrombosis and Thrombolysis | 2012年 / 33卷
关键词
Atrial fibrillation; C-reactive protein; Soluble thrombomodulin; Cardiac biomarkers; Cardiac rhythm;
D O I
暂无
中图分类号
学科分类号
摘要
C-reactive protein (CRP) is increased in patients with atrial fibrillation (AF) and it might predict the lack of sinus rhythm maintenance in the long term follow-up. Scarce data have been reported relating endothelial dysfunction and/or haemostatic or platelet markers to sinus rhythm maintenance in AF patients. We aimed to determine whether some biochemical markers including soluble thrombomodulin (sTM), soluble P-selectin, thrombin–antithrombin (TAT) complex and CRP levels could predict sinus rhythm maintenance at 1 year follow-up in non-valvular AF patients. 130 patients (70 males, mean age 67 ± 13 years) with newly diagnosed AF naïve of antithrombotic or antiplatelet therapy were studied. Baseline CRP, P-selectin, sTM and TAT levels were compared to those of 20 matched-healthy subjects in sinus rhythm. AF patients had significantly higher plasma CRP (10.5 ± 2.2 vs 3.25 ± 0.3 mg/l, p = 0.001), P-selectin (219 ± 141 vs 126 ng/ml, p = 0.01), and TAT (54 ± 237 vs 2.7 ± 3.3 ng/l, p = 0.001) levels compared with controls. Soluble TM levels, although higher than controls, did not reach statistical significance. Multivariate regression analyses showed that elevated CRP (OR = 4.8, p = 0.02) and sTM (OR = 1.05, p = 0.04) were the only two predictors of lack of sinus rhythm at 1 year follow-up. An altered inflammatory, haemostatic, endothelial and platelet environment exists in newly diagnosed AF patients. CRP and sTM levels might be used as biochemical markers to predict the status of cardiac rhythm at 1 year follow-up in some AF patients.
引用
收藏
页码:383 / 388
页数:5
相关论文
共 50 条
  • [21] Cardiac troponin I: Prothrombotic risk marker in non-valvular atrial fibrillation
    Providencia, Rui
    Paiva, Luis
    Faustino, Ana
    Botelho, Ana
    Trigo, Joana
    Casalta-Lopes, Joao
    Nascimento, Jose
    Leitao-Marques, Antonio Manuel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 877 - 882
  • [22] Observational study of the prevalence of non-valvular atrial fibrillation and ischemic stroke and the factors associated with non-valvular atrial fibrillation in hypertensive patients: about 2887 cases
    Bahloul, Amine
    Bouattour, Nadia
    Triki, Faten
    Hammami, Rania
    Charfeddine, Selma
    Ellouze, Tarek
    Mhiri, Chokri
    Abid, Leila
    Kammoun, Samir
    PAN AFRICAN MEDICAL JOURNAL, 2021, 38 : 1 - 11
  • [23] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [24] Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
    Kocis P.T.
    Liu G.
    Makenbaeva D.
    Trocio J.
    Velott D.
    Trainer J.A.B.
    Abdulsattar Y.
    Molina M.I.
    Leslie D.L.
    Drugs - Real World Outcomes, 2016, 3 (2) : 165 - 173
  • [25] A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
    Song, Ziliang
    Xu, Kai
    Hu, Xiaofeng
    Jiang, Weifeng
    Wu, Shaohui
    Qin, Mu
    Liu, Xu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [26] Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry
    Kodani, Eitaro
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    Okumura, Ken
    Yamashita, Takeshi
    Origasa, Hideki
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2018, 4 (01) : 59 - 68
  • [27] Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation
    Suzuki, Tsuyoshi
    Shiga, Tsuyoshi
    Omori, Hisako
    Tatsumi, Fujio
    Nishimura, Katsuji
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 238 - 243
  • [28] Impact of age on thromboembolic events in patients with non-valvular atrial fibrillation
    Kim, Yun Gi
    Choi, Jong-Il
    Boo, Ki Yung
    Kim, Do Young
    Hong, Yeji
    Kim, Min Sun
    Lee, Kwang-No
    Shim, Jaemin
    Kim, Jin Seok
    Kim, Young-Hoon
    CLINICAL CARDIOLOGY, 2020, 43 (01) : 78 - 85
  • [29] Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
    Cui, Jing
    Xia, Shi-Jun
    Tang, Ri-Bo
    He, Liu
    Guo, Xue-Yuan
    Li, Song-Nan
    Liu, Nian
    Sang, Cai-Hua
    Long, De-Yong
    Du, Xin
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [30] Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
    Park, Yongwhi
    Kim, Kye Hwan
    Kang, Min Gyu
    Ahn, Jong-Hwa
    Jang, Jeong Yoon
    Park, Hyun Woong
    Koh, Jin-Sin
    Park, Jeong-Rang
    Hwang, Seok-Jae
    Jeong, Young-Hoon
    Hwang, Jin-Yong
    Lee, Hye Ryun
    Kwak, Choong Hwan
    KOREAN CIRCULATION JOURNAL, 2017, 47 (03) : 366 - 376